Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Acetylcysteine and Bleomycin

supplement:

Acetylcysteine

Research Papers that Mention the Interaction

Coincubation of bleomycin with NAC reversed effects caused by bleomycin.
Biochimica et biophysica acta  •  2016  |  View Paper
We conclude that NAC has antagonistic effects on Bleomycin‐induced apoptosis in NT2 cells and causes resistance to apoptosis which is not a desired effect in eliminating cancer cells.
Journal of cellular biochemistry  •  2013  |  View Paper
Co-incubation with NAC significantly decreased lipid hydroperoxide, 8-isoprostane, protein carbonyl content and TBARS levels increased by bleomycin and H(2)O(2).
It can be concluded that NAC diminishes oxidative stress in human testicular cancer cells induced by bleomycin and H(2)O(2).
Biochimie  •  2012  |  View Paper
Co-incubation of NCCIT cells with bleomycin and 10 mM NAC abolished bleomycin-induced increases in caspase-3 and caspase-9 activities, Bax, and Cyt-c levels and bleomycin-induced decrease in Bcl-2 level.
Journal of Physiology and Biochemistry  •  2012  |  View Paper
As expected on this basis, the diamine WR‐1065 is a more effective potentiator of BLM than is the monoamine CSM, whereas cysteine and N‐acetylcysteine (NAC), which lack a net positive charge, potentiate BLM only weakly.
Environmental and molecular mutagenesis  •  2001  |  View Paper
NAC attenuated BLM induced oxidative damage, changes in E-cadherin and vimentin expressions and collagen deposition in the sclerotic skin of mice.
Toxicology and applied pharmacology  •  2014  |  View Paper
The increased malondialdehyde equivalents and carbonyl contents in lung tissue produced by BLM were also prevented by NAC plus DFX.
The results of total cell counts and neutrophils and LDH increased after BLM exposure and were reduced with NAC.
Pulmonary pharmacology & therapeutics  •  2008  |  View Paper
Bleomycin administration resulted in prominent lung fibrosis as measured by lung hydroxyproline content and lung histology which is almost completely prevented by erdosteine and NAC.
Pulmonary pharmacology & therapeutics  •  2005  |  View Paper
At 15 days postbleomycin, N‐acetylcysteine decreased collagen deposition in bleomycin‐exposed rats (hydroxyproline content: 6351±669 and 4626±288 μg per lung in drug vehicle‐ and N‐acetylcysteine‐treated rats, respectively; P<0.05).
These results indicate that N‐acetylcysteine reduces the primary inflammatory events, thus preventing cellular damage and the subsequent development of pulmonary fibrosis in the bleomycin rat model.
British journal of pharmacology  •  2003  |  View Paper
Nrf-1 and -2 activation by bleomycin is inhibited by the ROS quenching agent N-acetylcysteine (NAC), but not by U-0126, a MEK1/2 inhibitor that blocks bleomycin-induced MAPK activation.
American journal of physiology. Lung cellular and molecular physiology  •  2002  |  View Paper
Show More